| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Institute of Biochemistry, University of Vienna, Währingerstrasse 17, A-1090 Vienna, Austria
2 Department of Virology and Oncopharmacology
and3 Department of Medical Chemistry, Sterling Research Group, 81 Columbia Turnpike, Rensselaer, New York 12144, U.S.A.
Four WIN compounds with anti-picornavirus activities were tested for their ability to stabilize human rhinovirus serotype 2 (HRV-2) against low pH-induced conformational changes in vitro, as determined by specific immunoprecipitation. These results were compared to the minimal inhibitory concentration (MIC) as measured in a plaque reduction assay. A direct relationship was observed between the concentration of the compound that prevented the low pH-induced conformational changes and the MIC, indicating that stabilization is an important element in the mode of action of these drugs against HRV-2.
Received 21 August 1990;
accepted 22 October 1990.
This article has been cited by other articles:
|
|
 |
|
  T. Konecsni, U. Berka, A. Pickl-Herk, G. Bilek, A. G. Khan, L. Gajdzig, R. Fuchs, and D. Blaas Low pH-Triggered Beta-Propeller Switch of the Low-Density Lipoprotein Receptor Assists Rhinovirus Infection J. Virol., November 1, 2009; 83(21): 10922 - 10930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Khan, J. Pichler, A. Rosemann, and D. Blaas Human Rhinovirus Type 54 Infection via Heparan Sulfate Is Less Efficient and Strictly Dependent on Low Endosomal pH J. Virol., May 1, 2007; 81(9): 4625 - 4632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vlasak, I. Goesler, and D. Blaas Human Rhinovirus Type 89 Variants Use Heparan Sulfate Proteoglycan for Cell Attachment J. Virol., May 15, 2005; 79(10): 5963 - 5970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brabec, G. Baravalle, D. Blaas, and R. Fuchs Conformational Changes, Plasma Membrane Penetration, and Infection by Human Rhinovirus Type 2: Role of Receptors and Low pH J. Virol., May 1, 2003; 77(9): 5370 - 5377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bayer, D. Schober, E. Prchla, R. F. Murphy, D. Blaas, and R. Fuchs Effect of Bafilomycin A1 and Nocodazole on Endocytic Transport in HeLa Cells: Implications for Viral Uncoating and Infection J. Virol., December 1, 1998; 72(12): 9645 - 9655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Lewis, B. Bothner, T. J. Smith, and G. Siuzdak Antiviral agent blocks breathing of the common cold virus PNAS, June 9, 1998; 95(12): 6774 - 6778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Schober, P. Kronenberger, E. Prchla, D. Blaas, and R. Fuchs Major and Minor Receptor Group Human Rhinoviruses Penetrate from Endosomes by Different Mechanisms J. Virol., February 1, 1998; 72(2): 1354 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bayer, D. Schober, M. Huttinger, D. Blaas, and R. Fuchs Inhibition of Clathrin-dependent Endocytosis Has Multiple Effects on Human Rhinovirus Serotype 2 Cell Entry J. Biol. Chem., February 2, 2001; 276(6): 3952 - 3962. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
